EVOKE PHARMA INC
Q3 2025 13F Holders
Symbol
EVOK
CUSIP
30049G302
Type
Equity
Class
COM
Num filings
15
Total reported value, excl. options
$2.94 M
Compare 2025 Q3 to
2025 Q2
2025 Q1
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type